TL
TCM Life Science Inc.
SEC filingBiotechnology · Newark, DE
Amount raised$17Ksold at filing
Total offeringNot stated
Investors in the raise2count reported to the SEC
FiledOct 26, 2026first sale Oct 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Ya-Chun WangExecutive Officer, Director
Huan-Chin HsuDirector
Executive officers, directors and promoters as listed on the Form D.